Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial-Reference-Cited by-同舟云学术

Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial

Published:2023-05 Issue: Volume:35 Page:42-47
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Rautenberg Tamlyn A.,Ng Shu Kay,George Gavin,Moosa Mahomed-Yunus S.,McCluskey Suzanne M.,Gilbert Rebecca F.,Pillay Selvan,Aturinda Isaac,Ard Kevin L.,Muyindike Winnie,Musinguzi Nicholas,Masette Godfrey,Pillay Melendhran,Moodley Pravi,Brijkumar Jaysingh,Gandhi Rajesh T.,Johnson Brent,Sunpath Henry,Bwana Mwebesa B.,Marconi Vincent C.,Siedner Mark J.

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference35 articles.

1. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa;Fox;J Acquir Immune Defic Syndr,2012

2. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa;Boulle;AIDS,2010

3. Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South Africa;Brijkumar;HIV Med,2022

4. Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda;Ssemwanga;J Antimicrob Chemother,2020

5. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014-July 2015;Bulage;BMC Infect Dis,2017